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polynucleotide kinase (PNK) and aprataxin, hence, the name PNK-and aprataxin-like factor (also APLF for aprataxin-and PNK-like factor) (1) (2) (3) (4) . The shared property is the binding to XRCC4, a key component of the NHEJ ligase complex.
PALF, PNK and aprataxin also all have an FHA (fork-head associated) domain. The FHA domain is the site of binding to XRCC4 (5) . The kinase, CK2, phosphorylates XRCC4 (5) , and this phosphorylated form of XRCC4 is necessary for the FHA domain of PALF, PNK and aprataxin to bind XRCC4 (1, 3) . PALF has also been reported to bind to Ku (1, 3) as well as DNA-PKcs (1) and is important for cell survival after low dose ionizing radiation (4) .
XRCC4 is a key component of the XLF:XRCC4:DNA ligase IV complex, the primary ligase for vertebrate nonhomologous DNA end joining (NHEJ) (6, 7) . NHEJ is the major pathway for repair of double-strand breaks (DSBs), and includes the factors Ku, DNA-PKcs, Artemis, polymerase mu and polymerase lambda, as well. The nuclease activities of NHEJ are thought to be largely provided by Artemis (8) .
Artemis has endonucleolytic activity at all double-to singlestrand transitions (9) . For repair of DSBs, 5' overhangs, 3' overhangs, and hairpin structures are key substrates of Artemis. Artemis also appears to have 5' exonuclease activity, though mutagenesis has not yet definitively demonstrated this activity to be intrinsic to Artemis (10, 11) . Artemis and DNAPKcs form a tight complex, and Artemis endonucleolytic activity at double-to singlestrand transitions requires activation of DNAPKcs (8, 12) . DNA-PKcs is a serine/threonine protein kinase, which is only activated by duplex DNA ends.
When DNA-PKcs is activated by duplex DNA ends, it uses ATP to autophosphorylate itself and Artemis (8, 13) . The autophosphorylation causes a conformational change in DNA-PKcs (14, 15) , and this presumably causes a conformational change in Artemis to account for the activation of the endonucleolytic properties of Artemis (12) . When the C-terminal portion of Artemis is removed, Artemis acquires endonucleolytic properties independent of DNA-PKcs (16, 17) .
The nucleolytic properites of PALF have been described as a 3' exonuclease and a double-stranded DNA endonuclease (1) . PALF was also found to have nicking activity against various DNA molecules containing AP sites (1) . Here we confirm the 3' exonuclease activity of PALF (1) . The endonucleolytic properties of PALF appear to be more general than originally described.
PALF is able to endonucleolytically act on single-stranded DNA.
The previously described action at double-stranded DNA ends may simply reflect breathing of those ends into transient singlestranded tails. In contrast to Artemis, PALF is unaffected in its nucleolytic properties by DNAPKcs. PALF is also unaffected by Ku or by XRCC4:DNA ligase IV.
However, at incompatible ends with overhangs, we show that purified PALF is able to function in concert with purified Ku and XRCC4:DNA ligase IV in end joining reactions at an efficiency that is equivalent to when Artemis is used in place of PALF.
Finally, we find that in vivo siRNA knockdown of PALF results in a significant drop in joining of incompatible DNA ends.
Hence, PALF appears capable of participating in end joining with other NHEJ proteins. hydrochloride, pH 8.0, 1 mM EDTA, pH 8.0 and 100 mM NaCl and then heated at 100°C for 5 min, allowed to cool to room temperature for 3 hours, and then incubated at 4°C overnight.
EXPERIMENTAL PROCEDURES
The sequences of the oligonucleotides used in this study are as follows: JG68 : 5'-GAT CCT TCT GTA GGA CTC ATG-3'  JG169: 5'-TTT TTT TTT TTT TTT TTT TTT  TTT TTT TTT-3'   YM164: 5'-TTT TTG ATT ACT ACG GTA GTA  GCT ACG TAG CTA CTA CCG TAG TAA T-3'   YM130: 5'-TTT TTT TTT TTT TTT ACT GAG  TCC TAC AGA AGG ATC-3'   YM149: 5'-ACT GAG TCC TAC AGA AGG  ATC TTT TTT TTT TTT TTT-3'   YM8: 5'-AGG CTG TGT TAA GTA TCT GCG  CTC GCC CTC AGA GG-3'  YM9: 5'-CCT CTG AGG GCG AGC GCA GAT  ACT TAA CAC AGC CT-3'   JG258: 5'-CGA GCC CGA TCC GCT TGA CCA  GTA GTC TAG CAC GTG ACG ATT GCA TCC  GTC AAG TAA GAT GCA GAT ACT TAA CGG  GG-3'   SL11: 5'-GTT AAG TAT CTG CAT CTT ACT  TGA CGG ATG CAA TCG TCA CGT GCT AGA  CTA CTG GTC AAG CGG ATC GGG CTC  GCC CCA AAA AA-3'   SL15: 5'-ACT GAG TCC TAC AGA AGG ATC  TTT TTT TTT TTS SSS The sequence of siRNA for PALF; 5'-CCA GAU GAC UCC CAC AAA UAG was synthesized, annealed with a complementary strand and used with a final concentration of 20 µM. Antibody against PALF was prepared as previously reported (1) .
Protein expression and purification -Nterminal His-tagged PALF cloned into a pET16b (Novagen) vector has been described previously (1) . Soluble His-PALF is expressed and purified from pLysE BL21(DE3) competent cells (Invitrogen). Cells were pre-cultured in ampicillin until OD600 of 0.5. Cells were then induced with IPTG (1mM) and cultured for an additional 3 hours before harvesting. Harvested BL21(DE3) cells expressing His-PALF were resuspended in Ni-NTA binding buffer (50 mM NaH 2 PO 4 (pH 7.8), 0.5 M KCl, 2 mM beta-mercaptoethanol, 10% glycerol, 0.1% Triton X-100, and 20 mM imidazole (pH 7.8)) supplemented with protease inhibitors and lysed by sonication. The cell lysate was applied to a Ni-NTA agarose resin (Qiagen). Resin was washed with 35mM imidazole. His-PALF was eluted off with binding buffer plus 500 mM imidazole. Eluted fractions were dialyzed against Hi-Trap Heparin binding buffer(50 mM Tris-HCl (pH 7.5), 10% glycerol, 2 mM EDTA, 1 mM DTT, 100 mM NaCl, 0.02% NP-40), loaded onto preequilibrated Hi-Trap Heparin column, and eluted with a linear gradient to 1 M NaCl over 20 mL. We were able to obtain a yield of 200ug from a 1 liter starting culture. His-PALF containing fractions were reconcentrated onto Ni-NTA agrose and eluted in binding buffer plus 500mM of imidazole to a final elution volume of 200µl. His-PALF was then applied to a Superose 12 gel filtration column (GE Healthcare) and eluted with 250mM NaCl, 10% glycerol, 50mM Tris-HCl (pH 7.5), and 1mM DTT. PALF samples are stored at 4°C and used within 2 weeks because the nuclease activity of PALF is highly sensitive to freezing, as pointed out previously (1) .
The expression and purification of DNAPKcs from Hela cells has been previously described (8) . In vitro nuclease and ligation assaysWe extended the PALF nuclease optimizations done previously (1) by further testing activity in a range of pH (6.5 to 8), divalent cation concentration (0 to 20mM MgCl 2 ), and monovalent salt concentration (1mM to 100mM KCl). Based on this, in vitro DNA nuclease assays were performed in a total volume of 10 µl with a buffer composition of 25 mM Tris-HCl (pH 7.5), 10 mM KCl, 10 mM MgCl 2 , 1 mM DTT and 50 ng/µl BSA. In the reaction, 50 nM single-stranded DNA substrate with an overhang (3' or 5') or 20 nM hairpin substrate were incubated with 125 nM PALF and in specified cases one or more of the following: 126 nM DNA-PKcs, 100 nM Ku, 75nM XRCC4/LigIV, or a combination of the three proteins. In reactions containing XRCC4/LigIV, the XRCC4 and LigIV were prephosphorylated by CK2 according to manufacturer instructions (Sigma-Aldrich). Unless otherwise specified, when DNA-PKcs was present, 0.5 mM of ATP and 0.5 µM of 35bp blunt end DNA (YM 8/9) were also included in specified reactions. Reactions were then incubated at 37°C for 1 hour. After incubation, reactions were stopped and analyzed on 12% denaturing PAGE gels.
In vitro ligation assays were performed in a total volume of 10 µl with buffer composition 25mM Tris (pH 7.5), DTT 2mM, Triton x-100 0.025%, EDTA 0.1mM, PEG 10%, BSA 50ng/µl, glycerol 5%. In the in vitro ligation assay, a two-step reaction was performed. In the reaction, 50 nM doublestranded substrate (SL11/JG25) was incubated with 125 nM PALF and, in specified cases, one or more of the following 126 nM DNA-PKcs, 100 nM Ku, 75nM XRCC4/LigIV, or a combination of the three proteins. Unless otherwise specified, when DNA-PKcs was present, 0.5 mM of ATP and 0.5 µM of 35bp blunt end DNA (YM 8/9) were also included in the specified reactions. A two-step ligation reaction was carried out in the following order. PALF, substrate, and DNA-PKcs were first added to the reaction and incubated at 37°C for 30 minutes. LigaseIV:XRCC4 and Ku were then added and the reaction was incubated for another 30 minutes at 37°C. Reactions were stopped, DNA was phenol extracted and analyzed on 8% denaturing PAGE gel. Gels were dried, exposed in a phosphorimager cassette and scanned. Bands were cut out at the dimer position on ligation gels and Topo TA cloned into the Invitrogen pCR2.1-TOPO vector.
The insert was subsequently sequenced using a Li-Cor 4200 sequencer and the junctions were analyzed. NHEJ assay in living human cells. As previously reported (20) , the I-SceI expression plasmid, pCMV-3xNLS-I-SceI, was introduced by transfection with Lipofectamine 2000 reagent into 1.5 x 10 5 H1299dA3-1#1 cells harboring two I-SceI sites located 1.3 kb apart. The cells were pre-transfected with siRNA for 48 hr using Lipofectamin RNAiMAX. For FACS analysis, cells were harvested by trypsinization, washed with PBS, and applied to the FACS caliber apparatus (Beckton Dickinson). EGFP positive cells were counted by using the Cellquest software.
RESULTS
PALF has 3' single-stranded exonuclease activity -Previous data has demonstrated that PALF has AP-dependent endonuclease activity (1). We purified PALF using Ni-NTA, HiTrap heparin, and Superose 12 columns (Fig. 1A) and found it to have nuclease activity across an elution peak in proportion to the amount of protein visualized using Coomassie Blue staining ( Fig. 1A and B) .
Analysis of individual domains of PALF shows that the C terminal region, spanning amino acids (aa) 360-511, is necessary and sufficient to impart single-strand nuclease activity on the protein (Suppl. Fig. 1 & 2) . The aa 360-511 fragment alone contains all of the nucleolytic activity of the PALF protein (Suppl. Fig. 1 ). A truncation mutant lacking the aa 378-511 domain has no detectable nuclease activity in our assay (Suppl. Fig 2) . The aa 378-511 region contains two CYR motifs, also called PBZ motifs (poly [ADP-ribose] binding zinc-finger) .
We tested PALFs activity on a singlestranded DNA substrate to determine whether PALF has nuclease capabilities beyond those originally described. We designed a singlestranded poly dT 30mer labeled at the 5' end to investigate this ( Fig. 2A, lane 1) .
On this substrate, PALF generates a series of cleavage products ( Fig. 2A, lanes 2 ). The addition of DNA-PKcs and ATP does not increase or decrease the nuclease activity of PALF on single-stranded DNA (Fig. 2A, lane  3) .
Stimulation of DNA-PKcs autophosphorylation by the addition of unlabeled dsDNA, YM8/YM9, also did not affect the activity of PALF (Fig. 2A, lane 4) .
Artemis was used to generate a ladder starting at the 1 nucleotide position (Fig. 2A,  lane 5) .
PALF does not have any 5' exonuclease activity; unlike Artemis, no distinct product is formed at the 1 nucleotide position (Fig. 2A, lane 2 (10, 17) . MnCl 2 does not affect the activity of PALF (Fig. 2A, lane 6) .
To differentiate between these two activities, we labeled the same substrate at the 3' end (Fig. 2B, lanes 1-3) . Products generated by PALF from this substrate include a prominent band at the 1 nucleotide position (Fig. 2B, lane 2 and 3) , demonstrating definitive 3' exonuclease activity. However, a full range of larger products with a weaker profile is also present (Fig. 2B, lanes 2 and 3) . The amount of each species in this distribution of products increases relatively equally as the amount of enzyme is increased (twice as much PALF in lane 2 than lane 3). Given that the substrate was labeled at the 3' terminus, these weaker products can only be generated by the endonuclease activity of PALF acting on the single-stranded substrate.
Hence, we conclude that PALF has endonuclease activity on single-stranded DNA in addition to 3' exonuclease activity. PALF has single-stranded DNA endonuclease activity -If PALF has both 3' exonuclease activity and single-stranded endonuclease activity, then the endonuclease activity could potentially be masked on a single-stranded DNA substrate. To test for APindependent endonuclease activity, we designed substrates containing either a 15 nucleotide 3' overhang or a 14 nucleotide 5' overhang, both labeled at the 5' end (Fig. 3A , lane 1 for the 5' overhang substrate and Fig.  3B , lane 1 for the 3' overhang substrate). This endonuclease activity cleaves randomly within the 5' overhang. Unlike Artemis, the addition of DNA-PKcs did not further stimulate the endonuclease activity (Fig. 3a , lane 2 versus lane 3). Addition of unlabeled dsDNA to DNAPKcs (to stimulate autophosphorylation) also has no effect on the activity of PALF at the 5' overhang (Fig. 3a, lane 2 versus lane 3) . Hence, we conclude that unlike Artemis, PALF does not require DNA-PKcs for endonuclease activity at a 5' overhang.
Due to its ability to bind to Ku through an intermediate domain between the FHA domain and the CYR motif (PBZ motifs) of PALF (1,3), we tested whether the addition of Ku has an affect on nuclease activity of PALF at a 5' overhang. The addition of Ku along with DNAPKcs does not appear to modify PALF's activity (data not shown).
Earlier, we saw that the single-stranded DNA endonuclease activity of PALF is less efficient when 5' labeled single-stranded DNA substrates are cleaved to lengths smaller than 4 nt.
The single-stranded endonuclease activity also does not extend into the doublestranded portion of the DNA. This is indicated by the relative lack of bands above the 14 th nucleotide, counting from the bottom of the gel (Fig. 3A, lane 2) . (The very weak bands present between the 14th and 18th nucleotide may be due to breathing of the ss/dsDNA junction.) Hence, PALF does not appear to have significant activity on double-stranded DNA.
On a 5' labeled duplex DNA substrate with a 15 nt poly T 3' overhang, 9 to 10 distinct products are seen (Fig. 3B, lane 2) . PALF demonstrates endonuclease activity, but does not cleave at positions within 4 or 5 nts from the double-stranded portion of the substrate (Fig. 3B, lane 2) . The 3' overhang activity is not stimulated or blocked by the addition of DNA-PKcs and ATP (Fig. 3B, lane 3) . Further addition of unlabeled dsDNA, YM8/YM9, with DNA-PKcs also had no effect on the nuclease activity of PALF (Fig. 3B, lane 3) . The addition of Ku did not yield any changes when compared to the basal level with PALF alone (data not shown).
Like the 5' overhang substrate, no one cleavage product is dominant over any other; hence the nuclease activity on the single-stranded 3' overhang appears to be random in its position. PALF also has 3' exonuclease activity; therefore the activity we see at the 3' overhang is a combination of both endonuclease as well as 3' exonuclease activity on single-stranded regions.
When we position four phosphothioester linkages at the 3' end of the substrate, much less product is seen at the 3' overhang, indicating diminished 3' exonuclease activity (Suppl. Fig. 3, lane 2 vs. lane 4) . However, some product still remains, attributable to the endonuclease activity, which can nick 5' of the phosphothioester linkages. (Fig. 3B) . The ~4 or 5 nucleotides may reflect the minimum size required for PALF to bind to single-stranded DNA and act upon substrates. This is the same behavior as is seen for Artemis endonuclease action on 3' overhangs (Fig. 4 , lane 5; (8)). We conclude that PALF has single-stranded endonuclease activity, and this is distinct from its 3' exonuclease activity.
Due to the fact that PALF has endonuclease activity, we further investigated the possibility that PALF could potentially open a hairpin substrate like Artemis. A hairpin substrate with a 20 nucleotide duplex portion and a 6 nucleotide 5' overhang was used for this experiment (Fig. 4, lane 1) . When PALF alone is incubated with the substrate, four endonuclease products can be seen at the bottom of the gel (Fig. 4, lane 2) . This is consistent with the endonuclease activity we observed before for the 5' overhang substrate, YM130/YM68.
Once again we used Artemis:DNA-PKcs to generate a ladder to show the 1 nucleotide position and the hairpin opening product at the 28nt position (Fig. 4,  lane 5 ). This product is absent in the reaction where PALF alone is added (Fig. 4, lane 2) . The hairpin opening activity of Artemis is dependent upon DNA-PKcs, and we explored this possibility with respect to PALF. DNAPKcs and ATP were added to the reaction in addition to PALF. This did not stimulate PALF to cleave the hairpin, and no additional endonuclease activity is seen (Fig. 4, lane 3) . Further stimulation of DNA-PKcs by unlabeled DNA YM8/9 also did not stimulate PALF to cleave a hairpin substrate (Fig. 4, lane 4) . Therefore, unlike Artemis, PALF does not show DNA-PKcs-dependent ability in opening hairpin substrates (Fig. 4, lane 4 versus lane 5) . The endonuclease activity further supports our previous findings of PALF activity at a 5' overhang. The nuclease activity of PALF is not affected by Ku or XRCC4:DNA ligase IVPrevious data has demonstrated binding of PALF to XRCC4 via the FHA domain of PALF, and binding to Ku through a region in PALF between the FHA domain and the two CYR (PBZ) motifs. We wanted to investigate the possibility that the XRCC4:DNA ligase IV complex or Ku can enhance or block the exonuclease or endonuclease activity of PALF. As above, a single-stranded poly T substrate labeled at the 5' end was used in incubations with PALF for 1 hr with or without purified XRCC4:ligase IV or Ku. The basal activity of PALF generates a combination of endonuclease products and 3' exonuclease products (Fig. 5, lane 2) . XRCC4:DNA ligase IV, after being phosphorylated by CK2, was run alone to rule out the possibility of contamination (Fig. 5, lane 3) . XRCC4:DNA ligase IV without phosphorylation was also used as a negative control (Fig. 5, lane 4) . The addition of XRCC4:ligase IV did not produce a significant change over basal PALF activity (Fig. 5, lane 2 versus lane 5) . A combination of Ku and XRCC4:ligase IV also did not change the product profile (data now shown).
Finally, a combination of PALF, XRCC4:ligase IV, and DNA-PKcs failed to have any effects relative to PALF alone (Fig. 5 , lane 2 versus lane 6). This is noteworthy given that both Ku and XRCC4:ligase IV are known to bind to PALF, and DNA-PKcs is suggested to interact with PALF according to proteome analysis (1). Therefore, the interactions do not affect the nuclease activity of PALF. PALF is able to cooperate with other NHEJ factors to promote ligation in vitro and in vivo -Even though the core NHEJ factors did not stimulate the nuclease activity of PALF or permit it to open hairpins, we were interested in whether PALF could cooperate with other NHEJ factors to stimulate ligation in an in vitro assay.
In particular, we wondered if the nuclease activities of PALF could substitute for those of Artemis in resecting overhangs. We tested this by using an oligonucleotide substrate (SL11/JG258) with four nucleotides of microhomology but which had six additional A nts attached to the 3' end that would require nucleolytic resection before the 4 nt of microhomology could be utilized for ligation. Successful ligation would result in the substrate ligated to another identical molecule in a head-to-tail fashion. When the DNA substrate (Fig. 6A, lane 1) is incubated with XRCC4:ligase IV complex and Ku, this results in a small basal amount of ligation versus substrate alone (Fig. 6A, lane 2 versus lane 1) . In the absence of known NHEJ factors, when PALF alone is added to the reaction (Fig. 6A, lane 3) , no ligation products are formed. However when PALF, Ku, and XRCC4:ligase IV are all present, ligation products are formed (Fig. 6A, lane 4) . PALF is able to significantly increase the amount of product formed versus the basal level (Fig. 6A, lane 4 versus lane 2) . The addition of DNA-PKcs to the reaction hinders the ligation process (Fig. 6A, lane 5) . It is thought that DNA-PKcs must dissociate before ligation of DNA ends can occur (8, 14, 15) . This process is thought to be facilitated by auto-phosphorylation of DNA-PKcs. However the precise mechanism is not well understood. In vitro, this process may be too slow in our ligation reactions and hence may inhibit the overall ligation efficiency.
The ligation product was subsequently cut out from the gel, cloned into a TA cloning vector, and then sequenced (see Exp. Procedures). We found that all ten of the joined product molecules had the six As resected, leaving only the four Cs at the 3' overhang (Fig. 6C) . This allows for efficient joining due to the microhomology between the 4 Cs on the top strand at the 3' terminus of one duplex substrate and the 4 Gs of the bottom strand of a second duplex substrate. This is also consistent with results above showing that the PALF nuclease activity terminates its cleavage 3 to 4 nucleotides away from the junction between the overhang and the doublestranded portion of a substrate.
We also compared the efficiency of ligation of PALF versus that of Artemis in an in vitro assay.
Using the same substrate (SL11/JG258), we added Ku and XRCC4:DNA ligase IV to Artemis or PALF. Artemis is able to resect the ends in a similar manner as PALF, resulting in ligation using terminal microhomology (Fig. 6B, lane 1) . Under the same conditions, PALF is also able to ligate the substrate with a similar efficiency as Artemis (Fig. 6B , lane 3 12% versus lane 1 16% and Suppl. Fig 4, lanes 4 versus 1) . In some assays, we also added NHEJ factors, XLF and polymerase mu, and observed indistinguishable results (Suppl. Fig. 4) .
In vivo, we find that knockdown of PALF using siRNA reduces rejoining of two incompatible I-SceI-generated DNA ends by 50% (18) (Fig. 7) . This is consistent with recent studies of others that also suggest a role for PALF in NHEJ (19) .
DISCUSSION
PALF is both a single-stranded DNA 3' exonuclease and a single-stranded DNA endonuclease -The Yasui laboratory was the first to demonstrate that PALF (also called APLF) has nuclease activity (1-3) . Here we confirm that PALF has 3' exonuclease activity on single-stranded DNA.
We have also found that PALF has endonuclease activity on single-stranded DNA. This activity is capable of cleaving at all sites of a single strand except for the last few nucleotides at the 5' end. In addition, this activity is able to cleave at all positions of 5' overhangs of duplex DNA except for the 5'-most few nucleotides of the overhang. Finally, this activity cleaves at all positions of 5' and 3' overhangs except for the ~4 nucleotides 3' to the boundary of the overhang with the duplex DNA (designated the 'no cleavage zone' in Fig.  8) .
Unification of the PALF nuclease activities -
We believe that the double-stranded DNA endonuclease activity described previously might be accounted for by the broader singlestranded DNA endonuclease activity described here. The transient breathing of a dsDNA end into single-stranded flaps, which is substantial (20) , could serve as a single-stranded substrate for this ssDNA endonuclease activity of PALF. Given the action of PALF on all single-stranded DNA, the endonuclease of PALF has a broader range of substrates than previously appreciated, thereby increasing its potential importance within the cell. In vitro and in vivo function of PALF with other NHEJ proteins -We did not see any stimulation or modification of PALF 3' exonuclease and single-stranded DNA endonuclease activity by Ku, DNA-PKcs, or XRCC4:DNA ligase IV.
Though studies indicate that Ku and XRCC4:DNA ligase IV each bind to PALF (1,3), these interactions do not appear to affect PALF enzymatically.
Importantly, we find that in an in vitro system consisting of PALF, Ku, XRCC4;DNA ligase IV is, indeed, able to join incompatible DNA ends as efficiently as a system consisting of Artemis;DNA-PKcs, Ku, and XRCC4:DNA ligase IV. Specifically, PALF is able to resect the incompatible portion of an overhang to a point at which XRCC4:DNA ligase IV is able to support efficient ligation. Interestingly, at the DNA sequence level, we did not observe any ligation products other than those with the four junctional nucleotides that provide the maximal terminal microhomology.
(This does not preclude the possibility that some junctions do contain only 3 nucleotides and make up a small minority of the products formed.) Usage of maximal microhomology could occur by (1) iterative removal of the As by the 3' exonuclease activity of PALF, or (2) the endonuclease PALF activity. We favor latter possibility because we did not see a more diverse set of products.
Could PALF and Artemis both function as nucleases in NHEJ? This appears likely based on our in vivo siRNA knockdown of PALF (Fig. 7) . Additionally PALF suppression results in cells that are sensitive to MMS (1) as well as sensitive to double-strand break agents (unpublished data). Artemis (in complex with DNA-PKcs) may be more efficient in cleaving long overhangs in an endonucleolytic manner (9) , whereas PALF has an active 3' exonuclease activity. Artemis alone (without DNA-PKcs) has a weak single-stranded endonuclease activity (10) , and PALF appears to be substantially stronger in this activity. Therefore, in several ways, the nucleolytic activities of Artemis and PALF are complementary to one another. Each reaction consists of 50nM of single-stranded DNA substrate (JG169) and 50nM of PALF.
Reactions were incubated for 2 hrs at 37˚C. After incubation, reactions were stopped and analyzed by 12% denaturing PAGE. In each reaction, 20 nM of hairpin DNA substrate, YM164, was incubated with 125 nM of PALF, 50nM
Artemis, 126 nM DNA-PKcs, 0.5 mM ATP and 0.5 µM YM8/9 in a 10 µl reaction for 60 minutes at 37°C. After incubation, reactions were stopped and analyzed by 12% denaturing PAGE. 
